GlassScriptPhysician profile
Clayton Petro
NPI 1821387549
$51,384.20
in general payments reported to CMS, 2019-2025
19 companies · $6,544 in 2025
The $6,544 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,797 · 2020: $366 · 2021: $308 · 2022: $2,519 · 2023: $3,703 · 2024: $34K · 2025: $6,544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $12K · Travel and Lodging: $8,735 · Food and Beverage: $4,304 · Honoraria: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,990.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,366.01 |
| Travel and Lodging | $8,734.98 |
| Food and Beverage | $4,303.56 |
| Honoraria | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $20,886.50 | 2022-2025 | Progrip, Signia, Sonicision |
| Tela Bio, INC. | $15,010.78 | 2021-2024 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| W. L. Gore & Associates, INC. | $5,789.07 | 2023-2025 | Gore Synecor Biomaterial, Gore Synecor Preperitoneal Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Davol INC. | $3,390.16 | 2019-2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $3,370.57 | 2019-2025 | Da Vinci Surgical System |
| Momentis Surgical INC. | $1,000.00 | 2024 | Anova Surgical System |
| Distalmotion US | $366.30 | 2025 | Dexter L6 Robot |
| Covidien LP | $307.65 | 2019 | |
| Ethicon US, LLC | $231.38 | 2019-2025 | Dermabond, Stratafix, Echelon; Endopath |
| Kerecis Limited | $162.72 | 2022 | |
| Innovation Technologies INC | $156.82 | 2025 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $152.88 | 2020 | |
| Baxter Healthcare | $145.07 | 2022-2025 | Perclot, Tisseel |
| Becton, Dickinson and Company | $136.45 | 2025 | Phasix Mesh |
| Heron Therapeutics, INC. | $117.27 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Access Systems, INC. | $68.83 | 2019 | |
| Integra Lifesciences Corporation | $60.11 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Boston Scientific Corporation | $31.64 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clayton Petro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.